Read by QxMD icon Read

Trachoma prevalence

(no author information available yet)
[This corrects the article DOI: 10.1371/journal.pntd.0004927.].
March 2018: PLoS Neglected Tropical Diseases
Tigist Astale, Eshetu Sata, Mulat Zerihun, Andrew W Nute, Aisha E P Stewart, Demelash Gessesse, Gedefaw Ayenew, Berhanu Melak, Melsew Chanyalew, Zerihun Tadesse, E Kelly Callahan, Scott D Nash
BACKGROUND: Trachoma is the leading infectious cause of blindness worldwide. In communities where the district level prevalence of trachomatous inflammation-follicular among children ages 1-9 years is ≥5%, WHO recommends annual mass drug administration (MDA) of antibiotics with the aim of at least 80% coverage. Population-based post-MDA coverage surveys are essential to understand the effectiveness of MDA programs, yet published reports from trachoma programs are rare. METHODS: In the Amhara region of Ethiopia, a population-based MDA coverage survey was conducted 3 weeks following the 2016 MDA to estimate the zonal prevalence of self-reported drug coverage in all 10 administrative zones...
February 16, 2018: PLoS Neglected Tropical Diseases
Joana Favacho, Antonio José Ledo Alves da Cunha, Samara Tatielle Monteiro Gomes, Felipe Bonfim Freitas, Maria Alice Freitas Queiroz, Antonio Carlos Rosário Vallinoto, Ricardo Ishak, Marluísa de Oliveira Guimarães Ishak
Trachoma is the leading infectious cause of blindness in the world and is associated with precarious living conditions in developing countries. The aim of the present study was to evaluate the prevalence of trachoma in three municipalities of the Marajó Archipelago, located in the state of Pará, Brazil. In 2008, 2,054 schoolchildren from the public primary school system of the urban area of the region and their communicants were clinically examined; in 2016, 1,502 schoolchildren were examined. The positive cases seen during the clinical evaluation were confirmed by direct immunofluorescence (DIF) laboratory tests...
February 15, 2018: PLoS Neglected Tropical Diseases
Lamine Traoré, Benoit Dembele, Modibo Keita, Steven Reid, Mahamadou Dembéle, Bréhima Mariko, Famolo Coulibaly, Whitney Goldman, Dramane Traoré, Daouda Coulibaly, Boubacar Guindo, Joe Amon, Marily Knieriemen, Yaobi Zhang
BACKGROUND: In 2009, three years after stopping mass treatment with azithromycin, a trachoma impact survey in four health districts in the Kayes region of Mali found a prevalence of trachomatous inflammation-follicular (TF) among children aged 1 to 9 years of >5% and a trachomatous trichiasis (TT) prevalence within the general population (≥1-year-old) of <1%. As a result, the government's national trachoma program expanded trichiasis surgery and related activities required to achieve trachoma elimination...
February 12, 2018: PLoS Neglected Tropical Diseases
Joshua V Garn, Sophie Boisson, Rebecca Willis, Ana Bakhtiari, Tawfik Al-Khatib, Khaled Amer, Wilfrid Batcho, Paul Courtright, Michael Dejene, Andre Goepogui, Khumbo Kalua, Biruck Kebede, Colin K Macleod, Kouakou IIunga Marie Madeleine, Mariamo Saide Abdala Mbofana, Caleb Mpyet, Jean Ndjemba, Nicholas Olobio, Alexandre L Pavluck, Oliver Sokana, Khamphoua Southisombath, Fasihah Taleo, Anthony W Solomon, Matthew C Freeman
BACKGROUND: Facial cleanliness and sanitation are postulated to reduce trachoma transmission, but there are no previous data on community-level herd protection thresholds. We characterize associations between active trachoma, access to improved sanitation facilities, and access to improved water sources for the purpose of face washing, with the aim of estimating community-level or herd protection thresholds. METHODS AND FINDINGS: We used cluster-sampled Global Trachoma Mapping Project data on 884,850 children aged 1-9 years from 354,990 households in 13 countries...
January 22, 2018: PLoS Neglected Tropical Diseases
Anna R Last, Sarah E Burr, Emma Harding-Esch, Eunice Cassama, Meno Nabicassa, Chrissy H Roberts, David C W Mabey, Martin J Holland, Robin L Bailey
BACKGROUND: Trachoma, a neglected tropical disease, is caused by ocular infection with Chlamydia trachomatis (Ct). The World Health Organization (WHO) recommends three annual rounds of community mass drug treatment with azithromycin (MDA) if the prevalence of follicular trachoma in 1-9 year olds (TF1-9) exceeds 10% at district level to achieve an elimination target of district-level TF1-9 below 5% after. To evaluate this strategy in treatment-naïve trachoma-endemic island communities in Guinea Bissau, we conducted a cross-sectional population-based trachoma survey on four islands...
December 28, 2017: Parasites & Vectors
Catherine E Oldenburg, Abdou Amza, Boubacar Kadri, Beido Nassirou, Sun Y Cotter, Nicole E Stoller, Sheila K West, Robin L Bailey, Travis C Porco, Bruce D Gaynor, Jeremy D Keenan, Thomas M Lietman
Repeated oral azithromycin distribution targeted only to children has proven effective in reducing the ocular Chlamydia that causes trachoma. Here, we assess whether an enhanced coverage target of at least 90% of children is superior to the World Health Organization recommendation of at least 80%. Twenty-four trachoma-endemic communities in Matamèye, Niger, were randomized to a single day of azithromycin distribution aiming for at least 80% coverage or up to 4 days of treatment and > 90% coverage of children under age 12...
December 18, 2017: American Journal of Tropical Medicine and Hygiene
Oscar Debrah, Ernest O Mensah, Laura Senyonjo, Dziedzom K de Souza, Tei E Hervie, David Agyemang, Didier Bakajika, Benjamin Marfo, Felix Ahorsu, Seth Wanye, Robin Bailey, Joseph B Koroma, Agatha Aboe, Nana-Kwadwo Biritwum
BACKGROUND: In order to achieve elimination of trachoma, a country needs to demonstrate that the elimination prevalence thresholds have been achieved and then sustained for at least a two-year period. Ghana achieved the thresholds in 2008, and since 2011 has been implementing its trachoma surveillance strategy, which includes community and school screening for signs of follicular trachoma and trichiasis, in trachoma-endemic districts. In 2015-2016, the country conducted a district level population-based survey to validate elimination of trachoma as a public health problem...
December 12, 2017: PLoS Neglected Tropical Diseases
Jacob T Cox, Harran Mkocha, Beatriz Munoz, Sheila K West
BACKGROUND: Associations between repeated ocular infections with Chlamydia trachomatis in childhood and conjunctival scarring in adulthood are well established. Trachomatous scarring (TS) in children has also been observed in hyper-endemic areas, but data are scant regarding childhood scarring in areas where trachoma has been reduced to hypo-endemic levels. METHODS/PRINCIPLE FINDINGS: In this cross-sectional study, a random sample of children, ages 1-9 years, were selected from 38 communities in the formerly hyper-endemic district of Kongwa, Tanzania...
December 12, 2017: PLoS Neglected Tropical Diseases
Sarah E Gwyn, Lingwei Xiang, Ram Prasad Kandel, Deborah Dean, Manoj Gambhir, Diana L Martin
The target end date for the global elimination of trachoma as a public health problem is 2020. As countries begin the process for submitting their dossier for the validation of elimination of trachoma as a public health problem, strategies for post-validation surveillance must be considered. Seroprevalence of antibodies against antigens from the causative bacteria Chlamydia trachomatis (Ct) in young children has been shown to reflect trachomatous inflammation-follicular (TF) rates in both endemic and previously endemic settings...
November 6, 2017: American Journal of Tropical Medicine and Hygiene
Louise Dyson, Michael Marks, Oliver M Crook, Oliver Sokana, Anthony W Solomon, Alex Bishop, David C W Mabey, T Déirdre Hollingsworth
Yaws is a disabling bacterial infection primarily found in warm and humid tropical areas. The World Health Organisation strategy mandates an initial round of total community treatment (TCT) with single-dose azithromycin followed either by further TCT or active case finding and treatment of cases and their contacts (the Morges strategy). We wish to investigate the effectiveness of the Morges strategy. We employ a stochastic household model to study the transmission of infection using data collected from a pre-TCT survey conducted in the Solomon Islands...
November 13, 2017: American Journal of Epidemiology
Beselam Tadesse, Alemayehu Worku, Abera Kumie, Solomon Abebe Yimer
BACKGROUND: Trachoma is chronic kerato conjunctivitis, which is caused by repeated infection with Chlamydia trachomatis bacterium. It is hyper endemic in many rural areas of Ethiopia. The objective of this study was to measure the effect of water, sanitation and hygiene interventions on active trachoma in selected woredas of North and South Wollo zones of Amhara Region, Ethiopia. METHODOLOGY: A community based quasi-experimental study was conducted from October 2014 to December 2015 among children aged 1-8 years at baseline and among one year older same children after intervention...
November 2017: PLoS Neglected Tropical Diseases
Stephanie J Migchelsen, Nuno Sepúlveda, Diana L Martin, Gretchen Cooley, Sarah Gwyn, Harry Pickering, Hassan Joof, Pateh Makalo, Robin Bailey, Sarah E Burr, David C W Mabey, Anthony W Solomon, Chrissy H Roberts
Trachoma is caused by Chlamydia trachomatis (Ct). It is targeted for global elimination as a public health problem. In 2014, a population-based cross-sectional study was performed in two previously trachoma-endemic areas of The Gambia. Participants of all ages from Lower River Region (LRR) (N = 1028) and Upper River Region (URR) (N = 840) underwent examination for trachoma and had blood collected for detection of antibodies against the Ct antigen Pgp3, by ELISA. Overall, 30 (1.6%) individuals had active trachoma; the prevalence in children aged 1-9 years was 3...
November 8, 2017: Scientific Reports
James A D Good, Martina Kulén, Jim Silver, K Syam Krishnan, Wael Bahnan, Carlos Núñez-Otero, Ingela Nilsson, Emma Wede, Esmee de Groot, Åsa Gylfe, Sven Bergström, Fredrik Almqvist
Chlamydia trachomatis is a global health burden due to its prevalence as a sexually transmitted disease and as the causative agent of the eye infection trachoma. We recently discovered 3-amido thiazolino 2-pyridones which attenuated C. trachomatis infectivity without affecting host cell or commensal bacteria viability. We present here the synthesis and evaluation of nonhydrolyzable amide isosteres based on this class, leading to highly potent 1,2,3-triazole based infectivity inhibitors (EC50 ≤ 20 nM).
November 3, 2017: Journal of Medicinal Chemistry
Guillaume Trotignon, Ellen Jones, Thomas Engels, Elena Schmidt, Deborah A McFarland, Colin K Macleod, Khaled Amer, Amadou A Bio, Ana Bakhtiari, Sarah Bovill, Amy H Doherty, Asad Aslam Khan, Mariamo Mbofana, Siobhain McCullagh, Tom Millar, Consity Mwale, Lisa A Rotondo, Angela Weaver, Rebecca Willis, Anthony W Solomon
BACKGROUND: The Global Trachoma Mapping Project (GTMP) was implemented with the aim of completing the baseline map of trachoma globally. Over 2.6 million people were examined in 1,546 districts across 29 countries between December 2012 and January 2016. The aim of the analysis was to estimate the unit cost and to identify the key cost drivers of trachoma prevalence surveys conducted as part of GTMP. METHODOLOGY AND PRINCIPAL FINDINGS: In-country and global support costs were obtained using GTMP financial records...
October 2017: PLoS Neglected Tropical Diseases
Sarah Gwyn, Gretchen Cooley, Brook Goodhew, Stephan Kohlhoff, Natalie Banniettis, Ryan Wiegand, Diana L Martin
Antibody responses to Chlamydia trachomatis (CT) antigens may be useful tools for surveillance of trachoma by estimating cumulative prevalence of infection within a population. Data were compared from three different platforms-multiplex bead array (MBA), enzyme-linked immunosorbent assay (ELISA), and lateral flow assay (LFA)-measuring antibody responses against the CT antigen protein plasmid gene product 3 (Pgp3). Sensitivity was defined as the proportion of specimens testing antibody positive from a set of dried blood spots from Tanzanian 1-9-year olds who were positive for CT nucleic acid of all nucleic acid amplification test (NAAT)-positive individuals ( N = 103)...
December 2017: American Journal of Tropical Medicine and Hygiene
Beselam Tadesse, Alemayehu Worku, Abera Kumie, Solomon Abebe Yimer
BACKGROUND: Trachoma is a disease of the eye, caused by the bacteria Chlamydia trachomatis, which can lead to blindness if left untreated. Ethiopia is one of the most trachoma-affected countries in the world. The objective of this study was to determine the prevalence of and associated risk factors for active trachoma among children in selected woredas of North and South Wollo Zones in Amhara Region, Ethiopia. METHODS: This study was a community-based, cross-sectional study, which was conducted from October to December 2014 among children aged 1-8...
October 9, 2017: Infectious Diseases of Poverty
Ayanaw Tsega Ferede, Abel Fekadu Dadi, Amare Tariku, Akilew Awoke Adane
BACKGROUND: Trachoma is an infectious eye disease caused by Chlamydia trachomatis, which is the leading infectious cause of blindness worldwide. In areas where trachoma is endemic, active trachoma is common among preschool-aged children, with varying magnitude. This study aimed to estimate the prevalence of active trachoma and associated risk factors among preschool-aged children in Dembia District, northwest Ethiopia. METHODS: A community-based cross-sectional survey was conducted among preschool-aged children of northwest Ethiopia...
October 9, 2017: Infectious Diseases of Poverty
Sheila K West, Andrea I Zambrano, Shekhar Sharma, Sailesh K Mishra, Beatriz E Muñoz, Laura Dize, Kathryn Crowley, Charlotte A Gaydos, Lisa A Rotondo
Importance: To verify districts for elimination of blinding trachoma, the World Health Organization requires a population-based surveillance survey for follicular trachoma (TF) and trachomatous trichiasis (TT) 2 years after mass drug administration (MDA) activities have ceased. However, it is unknown if 2 years provides enough time to discover reemergence. Objective: To determine the prevalence of trachoma from surveys among 4 districts in Nepal (Dailekh, Dang, Surkhet, and Kanchanpur) that had surveillance intervals of 2, 4, 8, and 10 years, respectively, after cessation of MDA...
November 1, 2017: JAMA Ophthalmology
Athumani M Ramadhani, Tamsyn Derrick, David Macleod, Patrick Massae, Tara Mtuy, David Jeffries, Chrissy H Roberts, Robin L Bailey, David C W Mabey, Martin J Holland, Matthew J Burton
Trachoma, caused by Chlamydia trachomatis, is the world's leading infectious cause of blindness and remains a significant public health problem. Much of trachomatous disease pathology is thought to be caused indirectly by host cellular and immune responses, however the immune response during active trachoma and how this initiates progressive scarring is not clearly understood. Defining protective vs. pathogenic immune response to C. trachomatis is important for vaccine design and evaluation. This study reports the baseline results of a longitudinal cohort of Tanzanian children, who were monitored for 4 years in order to determine the immunofibrogenic and infectious correlates of progressive scarring trachoma...
2017: Frontiers in Cellular and Infection Microbiology
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"